Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Call for papers

Orthoflaviviruses: Insights into Molecular Biology, Epidemiology, and Control

Orthoflaviviruses, including Dengue, Zika, yellow fever, and West Nile viruses, are transmitted primarily by mosquitoes and ticks, causing significant health issues worldwide. Addressing the global burden of these viruses highlights the critical need for advanced prevention, treatment, and control strategies. Currently open for submissions - Submit Here

Guest Edited by:
Professor Olli Vapalahti, PhD, Department Virology, Helsinki University Hospital, University of Helsinki, Finland
Professor Denis Kainov, PhD, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norway

World Aids Day

For this cross-journal article collection, we welcome submissions from researchers, scientists, clinicians, and academics who are engaged in the scientific study of HIV/AIDS.  Currently open for submissions - Submit Here

Coronaviruses: emerging and re-emerging pathogens in humans and animals

This thematic series emphasizes advances and key discoveries in the animal origin, viral evolution, epidemiology, diagnostics and pathogenesis of different emerging and re-emerging coronaviruses. Currently open for submissions - Submit Here

Edited by Susanna K. P. Lau, Hayes Luk, Siddharth Sridhar, and Linfa Wang

Global Virus Network - Pandemic preparedness and prevention

New Content Item (8)Virology Journal is proud to announce our collaboration with the Global Virus Network (GVN), a premier international coalition of medical virology centres, to further our shared mission of advancing the global understanding of viruses and viral diseases.

Through this partnership, Virology Journal aims to amplify the impact of cutting-edge research by providing a platform for the GVN by publishing a series of commentaries on the theme of pandemic prevention. We look forward to the enriched content and insights this collaboration will bring to our readers and the broader scientific community.

The commentaries can be found here.

Top Reviewers 2024

Virology Journal would like to thank all of our peer reviewers for their dedication and expertise. Their invaluable contributions have been instrumental in maintaining the high standards of the journal. We extend our thanks to each reviewer for their time, effort, and commitment to advancing scholarly research.

We are particularly pleased to recognise the most frequent reviewers of 2024, whose reliable work has significantly enhanced the quality of our publications:

  • Safia Samir, PhD, Theodor Bilharz Research Institute, Egypt
  • José Valter Joaquim Silva Júnior, PhD, Federal University of Santa Maria, Brazil
  • Li Wang, PhD, Everest Medicines, China
  • Stella Garcia Colombarolli, PhD, Oswaldo Cruz Foundation, Brazil
  • Divya Pathak, PhD, Stanford University, USA
  • Krupa Jani, MS, ASCP iMB, Memorial Sloan Kettering Cancer Centre, USA
  • Jussi Hepojoki, PhD, University of Helsinki, Finland
  • Tat Yin Chan, PhD, The University of Hong Kong, Hong Kong
  • Chien-Hung Chen, PhD, Kaohsiung Chang Gung Memorial Hospital, Taiwan

Trusted Reviewer Board

Virology Journal is looking to recruit additional reviewers to our Trusted Reviewer Board. The board is open to early-career Virology researchers who would like to gain peer-review experience. Reviewers work closely with the editorial board and will be asked to review one manuscript per month.

Apply here.

SDG3 & Me

Are you, or is someone you know, making a contribution to the UN's SDG3 by working to "ensure healthy lives and promote well-being for all at all ages"?  Read our blog post to learn how to raise awareness for your work through our blog series. Applications can be made via our Google Form.

Articles

Sign up to receive article alerts

Virology Journal is published continuously online-only. We encourage you to sign up to receive free email alerts to keep up to date with all of the latest articles by registering here.

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Article collections

Discover all the article collections published in Virology Journal. Find out more

Aims and scope

Virology Journal is an open access, peer reviewed journal that considers articles on all aspects of virology, including research on the viruses of animals, plants and microbes. The journal welcomes basic research as well as pre-clinical and clinical studies of novel diagnostic tools, vaccines and anti-viral therapies.

Read more

Journal Sections

Clinical Virology: Fred Kibenge, University of Prince Edward Island, Canada 
Emerging viruses: Tom Geisbert, University of Texas Medical Branch, USA
Hepatitis viruses: Wan-Long Chuang, Kaohsiung Medical University, Taiwan
Herpes viruses: Tony Cunningham, The Westmead Institute for Medical Research, Australia
Influenza viruses: Hualan Chen, Chinese Academy of Agricultural Sciences, China
Negative-strand RNA viruses: John Barr, University of Leeds, UK
Other viruses: Erna Geessien Kroon, Universidade Federal de Minas Gerais, Brazil
Plant viruses: Supriya Chakraborty, Jawaharlal Nehru University, India
Positive-strand RNA viruses: Jaquelline Germano de Oliveira, Fundação Oswaldo Cruz - Fiocruz, Brazil 
Public health:  Kin On Kwok, The Chinese University of Hong Kong
Retroviruses: Aguinaldo Pinto, Universidade Federal de Santa Catarina, Brazil
Veterinary DNA viruses: Walid Azab, Freie Universität Berlin, Germany
Veterinary RNA viruses: James Weger-Lucarelli, Virginia Tech, USA
Viruses of microbes: Joana Azeredo, University of Minho, Portugal

Announcing the launch of In Review

Virology Journal, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:

  • Share their work with fellow researchers to read, comment on, and cite even before publication
  • Showcase their work to funders and others with a citable DOI while it is still under review
  • Track their manuscript - including seeing when reviewers are invited, and when reports are received 

Alan McLachlan, Co-Editor-in-Chief

Alan McLachlan is a molecular geneticist and hepadnavirologist. He currently serves as a Professor in the Department of Microbiology and Immunology, University of Illinois Chicago, USA. His interests are focused on hepatitis viruses, primarily on hepatitis B virus (HBV) and its relationships to liver physiology.  His research is currently directed toward understanding the relationships between HBV transcription and viral biosynthesis using both cell culture and animal models.  His long-term goals include the identification of cellular gene products as targets for the development of small molecular weight antiviral compounds which, in combination with current nuceot(s)ide analog therapeutics, will resolve chronic HBV infections.

Leo Poon, Co-Editor-in-Chief

Leo Poon is a molecular virologist. He currently serves as a Professor in the School of Public Health, The University of Hong Kong and as a co-director of HKU-Pasteur Research Pole. He has strong interests in emerging viruses, including coronavirus and influenza virus. He researches on different aspects of these viruses, ranging from basic virology to clinical diagnosis. His ultimate goal is to use scientific findings to inform public health policy. Over the years, he has published about 290 peer-reviewed articles. Thus far, his work has been cited over 41,000 times and he has an H-index of 95 (Web of Science).

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 4.0
    5-year Journal Impact Factor: 3.8
    Source Normalized Impact per Paper (SNIP): 0.971
    SCImago Journal Rank (SJR): 1.016

    Speed 2024
    Submission to first editorial decision (median days): 12
    Submission to acceptance (median days): 94

    Usage 2024
    Downloads: 2,767,001
    Altmetric mentions: 7,066